Live Breaking News & Updates on Mnov

Stay informed with the latest breaking news from Mnov on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mnov and stay connected to the pulse of your community

MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research note issued to investors on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Trading Down 2.4 % NASDAQ MNOV opened at $2.05 on Monday. The business’s 50-day moving average price is $2.34 and its 200 day […]

United-states , Blackrock , Nova-scotia , Canada , Montreal , Quebec , Zurich , Züsz , Switzerland , Blackrock-inc , Bank-julius-baer-co

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a research report issued on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. MediciNova Trading Down 1.4 % NASDAQ MNOV opened at $2.12 on Monday. The firm’s 50 day simple moving average is $2.35 and […]

United-states , Dimensional-fund-advisors , Squarepoint-ops , Medicinova-company-profile , Medicinova-inc , Virtu-financial , Morgan-stanley , Get-free-report , Nova-trading-down , Point-capital-management , Fund-advisors

MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report issued on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Price Performance MediciNova stock opened at $2.25 on Friday. MediciNova has a 1-year low of $1.89 and a 1-year high of $2.73. The stock has a […]

United-states , Dimensional-fund-advisors , Morgan-stanley , Virtu-financial , Medicinova-inc , Squarepoint-ops , Free-report , Get-free-report , Point-capital-management , Fund-advisors , Medicinova-daily

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report sent to investors on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Trading Down 0.9 % MediciNova stock opened at $2.25 on Friday. MediciNova has a 1-year low of $1.89 and a 1-year high of […]

United-states , Medicinova-company-profile , Virtu-financial , Medicinova-inc , Squarepoint-ops , Morgan-stanley , Dimensional-fund-advisors , Free-report , Nova-trading-down , Get-free-report , Point-capital-management

MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report issued on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Performance MNOV stock opened at $2.38 on Monday. The company has a market capitalization of $116.74 million, a P/E ratio of -8.81 and a […]

United-states , Renaissance-technologies , Jpmorgan-chase-co , Dimensional-fund-advisors , Medicinova-inc , Free-report , Get-free-report , Street-corp , Fund-advisors , Medicinova-daily , Medicinova

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com

Investment analysts at StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. MediciNova Price Performance Shares of MNOV opened at $2.38 on Monday. The firm has a 50-day moving average […]

United-states , Morgan-stanley , Virtu-financial , Dimensional-fund-advisors , Squarepoint-ops , Medicinova-inc , Medicinova-company-profile , Get-free-report , Point-capital-management , Fund-advisors , Medicinova-daily

MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research note released on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Performance MediciNova stock opened at $2.41 on Friday. The company has a market capitalization of $118.21 million, a price-to-earnings ratio of -8.93 and a […]

United-states , Squarepoint-ops , Medicinova-company-profile , Capricorn-fund-managers-ltd , Medicinova-inc , Morgan-stanley , Virtu-financial , Free-report , Get-free-report , Point-capital-management , Medicinova-daily

MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research note published on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Price Performance Shares of MNOV stock opened at $2.41 on Friday. MediciNova has a 12-month low of $1.89 and a 12-month high of $2.73. […]

United-states , Virtu-financial , Morgan-stanley , Capricorn-fund-managers-ltd , Medicinova-inc , Medicinova-company-profile , Squarepoint-ops , Free-report , Get-free-report , Point-capital-management , Medicinova-daily

MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Price Performance Shares of NASDAQ:MNOV opened at $2.28 on Friday. The business’s 50 day moving average price is $2.20 and its 200-day […]

United-states , Medicinova-inc , Virtu-financial , Squarepoint-ops , Nasdaq , Morgan-stanley , Dimensional-fund-advisors , Free-report , Fund-advisors , Street-group , Medicinova-daily

MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report report published on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Trading Down 0.9 % NASDAQ:MNOV opened at $2.28 on Friday. The firm has a market cap of $111.83 million, a P/E ratio of […]

United-states , Nasdaq , Medicinova-inc , Capricorn-fund-managers-ltd , Squarepoint-ops , Morgan-stanley , Virtu-financial , Free-report , Nova-trading-down , Point-capital-management , Medicinova-daily